Ceruloplasmin regulates iron levels in the CNS and prevents free radical injury

Journal of Neuroscience

Volumn 22, Issue 15, 2002, Pages 6578-6586

  Patel, Bharatkumar N ^a   Dunn, Robert J ^a   Jeong, Suh Young ^a   Zhu, Qinzhang ^a   Julien, Jean Pierre ^a   David, Samuel ^a  

^a MONTREAL GENERAL HOSPITAL   (Canada)

Author keywords

Aceruloplasminemia; Ferroxidase; Free radicals; Iron; Lipid peroxidation; Neurodegeneration; Oxidative stress; Parkinson's disease

Indexed keywords

CERULOPLASMIN; FREE RADICAL; GLYCOSYLPHOSPHATIDYLINOSITOL; IRON; TRANSFERRIN;

ALZHEIMER DISEASE; ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BRAIN STEM; CEREBELLUM; CEREBELLUM CORTEX; CONTROLLED STUDY; DEGENERATIVE DISEASE; DOPAMINERGIC NERVE CELL; GENE CASSETTE; IRON BLOOD LEVEL; IRON METABOLISM; IRON STORAGE; IRON TRANSPORT; LIPID PEROXIDATION; MOTOR COORDINATION; MOTOR DEVELOPMENT; MOUSE; NERVE CELL CULTURE; NERVE DEGENERATION; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENILE PLAQUE; SUBSTANTIA NIGRA;

EID: 0036703490     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.22-15-06578.2002     Document Type: Article

References (50)

1. Andrews NC (1999) The iron transporter DMT1. Int J Biochem Cell Biol 31:991-994.
2. Boll M-C, Sotelo J, Otero E, Alcaraz-Zubeldia M, Rios C (1999) Reduced ferroxidase activity in the cerebrospinal fluid from patients with Parkinson's disease. Neurosci Lett 265:155-158.
3. Borg DC, Schaich KM (1986) Prooxidant action of desferrioxamine: Fenton-like production of hydroxyl radicals by reduced ferrioxamine. J Free Radic Biol Med 2:237-243.
4. 2 in NF-kappaB activation by either cytokine in both primary and transformed endothelial cells. J Biol Chem 272:25941-25950.
5. Choi SY, Kwon HY, Kwon OB, Eum WS, Kang JH (2000) Fragmentation of human ceruloplasmin induced by hydrogen peroxide. Biochimie 82:175-180.
6. Connor JR, Tucker P, Johnson M, Snyder B (1993) Ceruloplasmin levels in the human superior temporal gyrus in aging and Alzheimer's disease. Neurosci Lett 159:88-90.
7. De Silva DM, Askwith CC, Kaplan J (1996) Molecular mechanisms of iron uptake in eukaryotes. Physiol Rev 76:31-47.
8. Donovan A, Brownlie A, Zhou Y, Shepard J, Pratt SJ, Moynihan J, Paw BH, Drejer A, Barut B, Zapata A, Law TC, Brugnara C, Lux SE, Pinkus GS, Pinkus JL, Kingsley PD, Palis J, Fleming MD, Andrews NC, Zon LI (2000) Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter. Nature 403:776-781.
9. Fleming RE, Gitlin JD (1990) Primary structure of rat ceruloplasmin and analysis of tissue-specific gene expression during development. J Biol Chem 265:7701-7707.
10. Frazer DM, Vulpe CD, McKie AT, Wilkins SJ, Trinder D, Cleghorn GJ, Anderson GJ (2001) Cloning and gastrointestinal expression of rat hephaestin: Relationship to other iron transport proteins. Am J Physiol Gastrointest Liver Physiol 281:G931-G939.
11. Frey D, Schneider C, Xu L, Borg J, Spooren W, Caroni P (2000) Early and selective loss of neuromuscular synapse subtypes with low sprouting competence in motoneuron diseases. J Neurosci 20:2534-2542.
12. Gerlach M, Ben-Shachar D, Riederer P, Youdim MBH (1994) Altered brain metabolism of iron as a cause of neurodegenerative diseases? J Neurochem 63:793-807.
13. Gitlin JD (1998) Aceruloplasminemia. Pediatr Res 44:271-276.
14. Gutteridge JM (1992) Iron and oxygen radicals in brain. Ann Neurol 32:S16-S21.
15. Han J, Day JR, Thomson K, Connor JR, Beard JL (2000) Iron deficiency alters H- and L-ferritin expression in rat brain. Cell Mol Biol 46:517-528.
16. Hansen MB, Nielsen SE, Berg K (1989) Reexamination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J Immunol Methods 119:203-210.
17. Harris ZL, Takahashi Y, Miyajima H, Serizawa M, MacGillivary RT, Gitlin JD (1995) Aceruloplasminemia: Molecular characterization of this disorder of iron metabolism. Proc Natl Acad Sci USA 92:2539-2543.
18. Harris ZL, Durley AP, Man TK, Gitlin JD (1999) Targeted gene disruption reveals an essential role for ceruloplasmin in cellular iron efflux. Proc Natl Acad Sci USA 96:10812-10817.
19. Hellman NE, Kono S, Miyajima H, Gitlin JD (2002) Biochemical analysis of a missense mutation in aceruloplasminemia. J Biol Chem 277:1375-1380.
20. Hussain S, Slikker Jr W, Ali SF (1995) Age-related changes in antioxidant enzymes, superoxide dismutase, catalase, glutathione peroxidase and glutathione in different regions of mouse brain. Int J Dev Neurosci 13:811-817.
21. 2 in vitro. Brain Res 671:181-186.
22. Joyner AL (1993) Gene targeting: A practical approach. Oxford: Oxford UP.
23. Klomp LW, Gitlin JD (1996) Expression of the ceruloplasmin gene in the human retina and brain: Implications for a pathogenic model in aceruloplasminemia. Hum Mol Genet 5:1989-1996.
24. Klomp LW, Farhangrazi ZD, Dugan LL, Gitlin JD (1996) Ceruloplasmin gene expression in the murine central nervous system. J Clin Invest 98:207-215.
25. Levin LA, Geszvain KM (1998) Expression of ceruloplasmin in the retina: Induction after optic nerve crush. Invest Ophthalmol Vis Sci 39:157-163.
26. Liu C, Weaver DR, Strogatz SH, Reppert SM (1997) Cellular construction of a circadian clock: Period determination in the suprachiasmatic nuclei. Cell 91:855-860.
27. Malecki EA, Devenyi AG, Beard JL, Connor JR (1999) Existing and emerging mechanisms for transport of iron and manganese to the brain. Neurosci Res 56:113-122.
28. McKie AT, Marciani P, Rolfs A, Brennan K, Wehr K, Barrow D, Miret S, Bomford A, Peters TJ, Farzaneh F, Hediger MA, Hentze MW, Simpson RJ (2000) A novel duodenal iron-regulated transporter, IREG1, implicated in the basolateral transfer of iron to the circulation. Mol Cell 5:299-309.
29. Mittal B, David S (1994) A monoclonal antibody that recognizes an adhesion molecule expressed by certain cells of neuroectodermal and mesenchymal origin. Mol Cell Neurosci 5:63-77.
30. Miyajima H, Nishimura Y, Mizoguchi K, Sakamoto M, Shimizu T, Honda N (1987) Familial apoceruloplasmin deficiency associated with blepharospasm and retinal degeneration. Neurology 37:761-767.
31. Morita H, Ikeda S, Yamamoto K, Morita S, Yoshida K, Nomoto S, Kato M, Yanagisawa N (1995) Hereditary ceruloplasmin deficiency with hemosiderosis: A clinicopathological study of a Japanese family. Ann Neurol 37:646-656.
32. Okamoto N, Wada S, Oga T, Kawabata Y, Baba Y, Habu D, Takeda Z, Wada Y (1996) Hereditary ceruloplasmin deficiency with hemosiderosis. Hum Genet 97:755-758.
33. Olanow CW (1993) A radical hypothesis for neurodegeneration. Trends Neurosci 16:439-444.
34. Osaki S, Johnson DA, Frieden E (1966) The possible significance of the ferrous oxidase activity of ceruloplasmin in normal human serum. J Biol Chem 241:2746-2751.
35. Ousman S, David S (2000) Lysophosphatidylcholine induces rapid recruitment and activation of macrophages in the adult mouse spinal cord. Glia 30:92-104.
36. Palmer C, Menzies SL, Roberts RL, Pavlick G, Connor JR (1999) Changes in iron histochemistry after hypoxic-ischemic brain injury in the neonatal rat. J Neurosci Res 56:60-71.
37. Patel BN, David S (1997) A novel glycosylphosphatidylinositol-anchored form of ceruloplasmin is expressed by mammalian astrocytes. J Biol Chem 272:20185-20190.
38. Patel BN, Dunn RJ, David S (2000) Alternative RNA splicing generates a glycosylphosphatidylinositol-anchored form of ceruloplasmin in mammalian brain. J Biol Chem 275:4305-4310.
39. Richardson DR (1999) Role of ceruloplasmin and ascorbate in cellular iron release. J Lab Clin Med 134:454-465.
40. Roskams AJ, Connor JR (1992) Transferrin receptor expression in myelin deficient (md) rats. J Neurosci Res 31:421-427.
41. Smith MA, Harris PL, Sayre LM, Perry G (1997) Iron accumulation in Alzheimer disease is a source of redox-generated free radicals. Proc Natl Acad Sci USA 94:9866-9868.
42. Steele PM, Medina JF, Nores WL, Mauk MD (1998) Using genetic mutations to study the neural basis of behavior. Cell 95:879-882.
43. Surai PF, Speake BK, Noble RC, Sparks NH (1999) Tissue-specific antioxidant profiles and susceptibility to lipid peroxidation of the newly hatched chick. Biol Trace Elem Res 68:63-78.
44. Torrance JD, Bothwell TH (1980) Tissue iron stores. In: Methods in Hematology: Iron (Cook JD, ed), pp 90-115. New York: Churchill Livingstone.
45. Vulpe CD, Kuo YM, Murphy TL, Cowley L, Askwith C, Libina N, Gitschier and Anderson GJ (1999) Hephaestin, a ceruloplasmin homologue implicated in intestinal iron transport, is defective in the sla mouse. Nat Genet 21:195-199.
46. Williams K, Wilson MA, Bressler J (2000) Regulation and developmental expression of the divalent metal-iron transporter in the rat brain. Cell Mol Biol 46:563-571.
47. Winterbourn CC (1995) Toxicity of iron and hydrogen peroxide: The Fenton reaction. Toxicol Lett 82-83:969-974.
48. Yoshida K, Furihata K, Takeda S, Nakamura A, Yamamoto K, Morita H, Hiyamuta S, Ikeda S, Shimizu N, Yanagisawa N (1995) A mutation in the ceruloplasmin gene is associated with systemic hemosiderosis in humans. Nat Genet 9:267-272.
49. Young SP, Fahmy M, Golding S (1997) Ceruloplasmin, transferrin and apotransferrin facilitate iron release from human liver cells. FEBS Lett 411:93-96.
50. Zahs KR, Bigornia V, Deschepper CF (1993) Characterization of "plasma proteins" secreted by cultured rat macroglial cells. Glia 7:121-133.